ArticleJMIR public health and surveillance2017
Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers.
Article in JMIR public health and surveillance, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.
- A systematic review on health systems integrated approach towards elimination of HIV, syphilis and viral hepatitis as public health threats in sub-Saharan Africa.The Pan African medical journal · 2026Pooled it
- Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.The lancet. Gastroenterology & hepatology · 2022Pooled it
- Estimating the Fraction of Hepatocellular Carcinoma and Decompensated Cirrhosis Attributable to Viral Hepatitis in England Using Electronic Health Records and Case-Notes Review.Journal of viral hepatitis · 2026Article
- Impact of educational interventions on hepatitis B and C awareness among school students of Delhi NCR, India.BMC public health · 2024Article
- Embedding viral hepatitis into primary healthcare: results of a strategic landscape analysis in Vietnam and the Philippines.The Lancet regional health. Western Pacific · 2024Review
- Detection of hepatitis viruses in suspected cases of Viral Haemorrhagic Fevers in Nigeria.PloS one · 2024Article
- Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.Journal of viral hepatitis · 2021Article
- A global investment framework for the elimination of hepatitis B.Journal of hepatology · 2021Article
- Burden of viral hepatitis caused by specific aetiologies in China, 1990-2016: findings from the GBD 2016.BMC public health · 2020Article
- Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.Clinical microbiology reviews · 2020Review
- The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges.Journal of preventive medicine and hygiene · 2020Article
- Help-Seeking Experiences of Hepatitis B Patients in Transnational Medical Care: The Solution to Health Inequality Is Social Mobility.Healthcare (Basel, Switzerland) · 2019Article
- Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017.JHEP reports : innovation in hepatology · 2019Article
- Comparison of prevention, screening and treatment of hepatitis C in Iran, Egypt and Georgia.Journal of virus eradication · 2019Article
- The hepatitis C infection in Iran: a policy analysis of agenda-setting using Kingdon's multiple streams framework.Health research policy and systems · 2019Article
- Neural-network analysis of socio-medical data to identify predictors of undiagnosed hepatitis C virus infections in Germany (DETECT).Journal of translational medicine · 2019Article
- Update on global epidemiology of viral hepatitis and preventive strategies.World journal of clinical cases · 2018Review
- Know Your Epidemic, Strengthen Your Response: Developing a New HIV Surveillance Architecture to Guide HIV Resource Allocation and Target Decisions.JMIR public health and surveillance · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 2 countries.
Funding
Abstract
Evidence documenting the global burden of disease from viral hepatitis was essential for the World Health Assembly to endorse the first Global Health Sector Strategy (GHSS) on viral hepatitis in May 2016. The GHSS on viral hepatitis proposes to eliminate viral hepatitis as a public health threat by 2030. The GHSS on viral hepatitis is in line with targets for HIV infection and tuberculosis as part of the Sustainable Development Goals. As coordination between hepatitis and HIV programs aims to optimize the use of resources, guidance is also needed to align the strategic information components of the 2 programs. The World Health Organization monitoring and evaluation framework for viral hepatitis B and C follows an approach similar to the one of HIV, including components on the following: (1) context (prevalence of infection), (2) input, (3) output and outcome, including the cascade of prevention and treatment, and (4) impact (incidence and mortality). Data systems that are needed to inform this framework include (1) surveillance for acute hepatitis, chronic infections, and sequelae and (2) program data documenting prevention and treatment, which for the latter includes a database of patients. Overall, the commonalities between HIV and hepatitis at the strategic, policy, technical, and implementation levels justify coordination, strategic linkage, or integration, depending on the type of HIV and viral hepatitis epidemics. Strategic information is a critical area of this alignment under the principle of what gets measured gets done. It is facilitated because the monitoring and evaluation frameworks for HIV and viral hepatitis were constructed using a similar approach. However, for areas where elimination of viral hepatitis requires data that cannot be collected through the HIV program, collaborations are needed with immunization, communicable disease control, tuberculosis, and hepatology centers to ensure collection of information for the remaining indicators.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.